Hemostatic Efficacy and Safety of 4-Factor Prothrombin Complex Concentrate in Doac-Associated Intracranial Hemorrhage.

Whaley, Patrick M; Franco-Martinez, Crystal; Lock, Ashley E; Ramaswamy, Davana; Young, Eric H; Allen, Stefan M; Barthol, Colleen A

Whaley, Patrick M; Franco-Martinez, Crystal; Lock, Ashley E; Ramaswamy, Davana; Young, Eric H; Allen, Stefan M; Barthol, Colleen A.

Afiliación

Whaley PM; 43159University Health, San Antonio, TX, USA.
Franco-Martinez C; UT Health San Antonio, San Antonio, TX, USA.
Lock AE; 15528The University of Texas at Austin College of Pharmacy, Pharmacotherapy Division, Austin, TX, USA.
Ramaswamy D; 43159University Health, San Antonio, TX, USA.
Young EH; UT Health San Antonio, San Antonio, TX, USA.
Allen SM; 15528The University of Texas at Austin College of Pharmacy, Pharmacotherapy Division, Austin, TX, USA.
Barthol CA; 43159University Health, San Antonio, TX, USA.

J Pharm Pract ; : 8971900221148034, 2022 Dec 23.

Article en En | MEDLINE | ID: mdl-36564900

Palabras clave

4-factor prothrombin complex concentrate; factor xa-hemorrhage treatment; intracranial hemorrhage

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: J Pharm Pract Asunto de la revista: FARMACIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google